Financing, Equity Capital Markets

Fulgent Genetics, Inc.

09/20
|
$125.0 Million
Piper Sandler served as left bookrunner for Fulgent Genetics, Inc. on an ATM offering
Sub-Type
At the Market Offering
Sub-Sector
Life Sciences Tools & Diagnostics